Gyre Therapeutics is trading 9.03% higher at $6.64 after an after-hours rebound; the catalyst remains unclear.
- Price context shows a sharp rebound after several declining closes; volume and activity data were not provided.
- The October 19 regular-session close was $6.09; the official press-release page lists September 3 as its latest release.
- Wall Street Zen’s October 19 downgrade was based on a Saturday note; H.C. Wainwright reiterated Buy, and neither report explicitly linked its rating to the rise.